Sustained Monomorphic Ventricular Tachycardia During Imatinib Therapy in Blast-Phase Chronic Myeloid Leukemia: A Case Report from a Resource-Limited Setting
Background: Imatinib has substantially improved the treatment of chronic myeloid leukemia (CML) and is generally associated with a favorable cardiovascular safety profile. Nevertheless, serious arrhythmias occurring during treatment may present a diagnostic challenge, particularly in patients with advanced disease and multiple potential contributing factors. Case presentation: A 45-year-old woman with CML in blast phase developed sustained monomorphic ventricular tachycardia (VT) during treatment with imatinib. Bone marrow examination showed 66% blasts, and her clinical course was complicated by severe anemia and metabolic abnormalities. During the arrhythmic episode, her heart rate was approximately 198 beats/min and blood pressure was 93/61 mmHg. She remained conscious, with palpable pulses and preserved peripheral perfusion. The ventricular tachycardia persisted despite two intravenous amiodarone loading doses and subsequently converted to sinus rhythm following synchronized electrical cardioversion. No recurrence was documented during the subsequent observation period. The event occurred in the setting of advanced malignancy and other potential clinical contributors, making its cause difficult to determine. Conclusion: This case illustrates the challenge of evaluating ventricular tachycardia in a patient with advanced CML receiving imatinib. A treatment-related arrhythmia is a possibility, but the clinical context includes several competing contributors and does not establish a definitive cause. Assessment of serious arrhythmias during cancer treatment should consider medication exposure, the underlying disease, and potentially reversible clinical factors.
Authors
- Selamawit Kassahun Aweke (ORCID: https://orcid.org/0009-0002-8212-7883)
- Leul Tesfaye Kidane
- Yohana Bezabih Kelile
- Abdulhakim Muste Awol
- Natnael Mathewos Assele
- Ruth Lesan Lakew
- Ayenew Amare Wole
Institutions
- Addis Ababa University (ET)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-11605710/v1
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- preprint